BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21398045)

  • 1. Glatiramer acetate could be a hypothetical therapeutic agent for neuromyelitis optica.
    Wang KC; Lee CL; Chen SY; Lin KH; Tsai CP
    Med Hypotheses; 2011 Jun; 76(6):820-2. PubMed ID: 21398045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and treatment of neuromyelitis optica.
    Wingerchuk DM
    Neurologist; 2007 Jan; 13(1):2-11. PubMed ID: 17215722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica: new findings on pathogenesis.
    Wingerchuk DM
    Int Rev Neurobiol; 2007; 79():665-88. PubMed ID: 17531863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica: an overview.
    Nandhagopal R; Al-Asmi A; Gujjar AR
    Postgrad Med J; 2010 Mar; 86(1013):153-9. PubMed ID: 20237009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
    Fujihara K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):883-5. PubMed ID: 18210826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
    Jarius S; Paul F; Franciotta D; Waters P; Zipp F; Hohlfeld R; Vincent A; Wildemann B
    Nat Clin Pract Neurol; 2008 Apr; 4(4):202-14. PubMed ID: 18334978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuromyelitis optica spectrum disorder: a case report].
    Mitsuyama T; Yoneyama T; Suzuki S; Kagawa M; Kawamata T
    No Shinkei Geka; 2012 Apr; 40(4):337-42. PubMed ID: 22466233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF; Kassab SL; Pittock SJ
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system.
    Argyriou AA; Makris N
    Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
    Liblau R
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Ziemssen T; Schrempf W
    Int Rev Neurobiol; 2007; 79():537-70. PubMed ID: 17531858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
    Patel V; Griffith NC; Blackwood E; Dias M; Cordato DJ
    J Clin Neurosci; 2012 Nov; 19(11):1576-8. PubMed ID: 22925418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P; Ravindran J; Cleland L; Limaye V
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.